US20070269370A1 - Compositions and methods for treating B-cell malignancies - Google Patents

Compositions and methods for treating B-cell malignancies Download PDF

Info

Publication number
US20070269370A1
US20070269370A1 US11/697,945 US69794507A US2007269370A1 US 20070269370 A1 US20070269370 A1 US 20070269370A1 US 69794507 A US69794507 A US 69794507A US 2007269370 A1 US2007269370 A1 US 2007269370A1
Authority
US
United States
Prior art keywords
cell
delivery system
drug delivery
protein
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/697,945
Other versions
US8067011B2 (en
Inventor
Claude Davis
Miguel de los Rios
Kenneth Oh
Timothy Bullock
Patrick Johnson
Jacek Ostrowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMED REALTY LP
Original Assignee
ANGELICA PHARMACEUTICALS
CHIMERACORE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US79032106P priority Critical
Priority to US11/697,945 priority patent/US8067011B2/en
Application filed by ANGELICA PHARMACEUTICALS, CHIMERACORE Inc filed Critical ANGELICA PHARMACEUTICALS
Assigned to CHIMERACORE, INC. reassignment CHIMERACORE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BULLOCK, TIMOTHY L., JOHNSON, PATRICK T., MIGUEL A. DE LOS RIOS, OH, KENNETH J., OSTROWSKI, JACEK
Assigned to ANGELICA PHARMACEUTICALS reassignment ANGELICA PHARMACEUTICALS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DAVIS, CLAUDE GEOFFREY
Publication of US20070269370A1 publication Critical patent/US20070269370A1/en
Assigned to CHIMEROS, INC. reassignment CHIMEROS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CHIMERACORE, INC.
Assigned to CHIMEROS, INC. reassignment CHIMEROS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ANGELICA THERAPEUTICS, INC.
Assigned to ANGELICA THERAPEUTICS, INC. reassignment ANGELICA THERAPEUTICS, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME. ASSIGNOR HEREBY CONFIRMS THE ASSIGNEE'S NAME FOR RECORDAL SHOULD HAVE READ ANGELICA THERAPEUTICS, INC. PREVIOUSLY RECORDED ON REEL 019569 FRAME 0544. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Assignors: DAVIS, CLAUDE GEOFFREY
Assigned to PROSPECT VENTURE PARTNERS III, L.P. reassignment PROSPECT VENTURE PARTNERS III, L.P. SECURITY AGREEMENT Assignors: CHIMEROS, INC.
Assigned to PROSPECT VENTURE PARTNERS III, L.P. reassignment PROSPECT VENTURE PARTNERS III, L.P. SECURITY AGREEMENT Assignors: CHIMEROS, INC.
Assigned to PROSPECT VENTURE PARTNERS III, L.P. AS COLLATERAL AGENT reassignment PROSPECT VENTURE PARTNERS III, L.P. AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: CHIMEROS, INC.
Assigned to BIOMED REALTY, L.P. reassignment BIOMED REALTY, L.P. SECURITY AGREEMENT Assignors: CHIMEROS, INC.
Publication of US8067011B2 publication Critical patent/US8067011B2/en
Application granted granted Critical
Assigned to BIOMED REALTY, L.P. reassignment BIOMED REALTY, L.P. ASSIGNMENT PURSUANT FORECLOSURE Assignors: CHIMEROS, INC.
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links